Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Research and development expenses, net		$ 2,515	$ 1,100
General and administrative expenses		4,729	4,167
Operating loss		7,244	5,267
Financing (income) expenses, net		(4)	2,322
Net loss and comprehensive loss		$ 7,240	$ 7,589
Net loss per share, basic and diluted	[1]	$ (2.41)	$ (2.76)
Weighted-average number of common shares outstanding, basic and diluted (*)	[1],[2]	2,904,253	2,178,827

[1] December 31, 2018 and 2017 shares data represents the number of shares adjusted to retroactively reflect the 1:15 Reverse Split effected on September 4, 2018. Refer to Note 1 for further information.

[2] December 31, 2017 share data represents the number of shares adjusted to retroactively reflect the 1:15 reverse stock split effected on September 4, 2018. Refer to Note 1 for further information.